Procalcitonin: Importance for the diagnosis of bacterial infections

被引:2
作者
Christ-Crain, Mirjarn [1 ]
Schuetz, Philipp [1 ]
Huber, Andreas R. [2 ]
Mueller, Beat [3 ]
机构
[1] Univ Basel Hosp, Bereich Innere Med, Basel, Switzerland
[2] Kantonsspital Aarau, Zentrum Lab Med, Aarau, Switzerland
[3] Kantonsspital Aarau, Bereich Med, Aarau, Switzerland
来源
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE | 2008年 / 32卷 / 06期
关键词
antibiotics; infection; pneumonia; procalcitonin;
D O I
10.1515/JLM.2008.063
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
In contrast to calcitonin, which is primarily synthesized in the thyroid, procalcitonin is a prohormone which is synthesized in many different tissues of infected organs. To diagnose mild, localized, or early infections an assay needs to have a functional assay sensitivity of approximately 0.02 mu g/L. We demonstrated that procalcitonin modifies the outcome of respiratory infections with regard to minimizing the use of antibiotics and duration of antibiotic treatment. High concentrations, especially over time, indicate high risk of a severe outcome. In this respect, procalcitonin is superior to other infection markers, such as C-reactive protein. High procalcitonin levels can also be found in non-bacterial diseases, such as malaria, severe trauma, burns, and medullar carcinoma of the thyroid. Procalcitonin, as a marker, has improved the diagnosis of bacterial infections. However, procalcitonin needs to be used in conjunction with other laboratory markers, clinical examination, and medical history.
引用
收藏
页码:425 / 433
页数:9
相关论文
共 57 条
[1]  
Al-Nawas B, 1996, Eur J Med Res, V1, P331
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]  
Becker K, 2001, PRINCIPLES PRACTICE, P520
[4]   Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors [J].
Becker, KL ;
Nylén, ES ;
White, JC ;
Müller, B ;
Snider, RH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1512-1525
[5]   Procalcitonin is a marker of severity of renal lesions in pyelonephritis [J].
Benador, N ;
Siegrist, CA ;
Gendrel, D ;
Greder, C ;
Benador, D ;
Assicot, M ;
Bohuon, C ;
Girardin, E .
PEDIATRICS, 1998, 102 (06) :1422-1425
[6]  
BRIEL M, 2008, ARCH INT ME IN PRESS
[7]   Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: Study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671] [J].
Briel M. ;
Christ-Crain M. ;
Young J. ;
Schuetz P. ;
Huber P. ;
Périat P. ;
Bucher H.C. ;
Müller B. .
BMC Family Practice, 6 (1)
[8]   Procalcitonin as a diagnostic aid in osteomyelitis and septic arthritis [J].
Butbul-Aviel, Y ;
Koren, A ;
Halevy, R ;
Sakran, W .
PEDIATRIC EMERGENCY CARE, 2005, 21 (12) :828-832
[9]   Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates [J].
Chiesa, C ;
Panero, A ;
Rossi, N ;
Stegagno, M ;
De Giusti, M ;
Osborn, JF ;
Pacifico, L .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (03) :664-672
[10]   Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections:: cluster-randomised, single-blinded intervention trial [J].
Christ-Crain, M ;
Jaccard-Stolz, D ;
Bingisser, R ;
Gencay, MM ;
Huber, PR ;
Tamm, M ;
Müller, B .
LANCET, 2004, 363 (9409) :600-607